$1.13
-0.005-0.44%
Last update: Dec 12, 11:45 AM
Comments
Loading...
Citius Oncology (CTOR) Stock Price, Quote, News & History
CTORNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Citius Oncology (CTOR) stock?
You can purchase shares of Citius Oncology (NASDAQ:CTOR) through any online brokerage.
Who are Citius Oncology (CTOR) competitors?
Other companies in Citius Oncology’s space includes: Macrogenics Inc (NASDAQ:MGNX), Outlook Therapeutics Inc (NASDAQ:OTLK), Tharimmune Inc (NASDAQ:THAR), Fortress Biotech Inc (NASDAQ:FBIO) and Zentalis Pharmaceuticals Inc (NASDAQ:ZNTL).
What is the forecast, or price target, for Citius Oncology (CTOR) stock?
Citius Oncology has a consensus price target of $6.00.
What is the current price for Citius Oncology (CTOR)?
The stock price for Citius Oncology (NASDAQ: CTOR) is $1.125 last updated December 12, 2025 at 11:45 AM EST.
Does Citius Oncology (CTOR) pay a dividend?
There are no upcoming dividends for Citius Oncology.
When is Citius Oncology (NASDAQ:CTOR) reporting earnings?
Citius Oncology does not have any upcoming earnings scheduled.
Is Citius Oncology (CTOR) going to split?
There is no upcoming split for Citius Oncology.
What sector and industry does Citius Oncology (CTOR) operate in?
Citius Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
